Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma

Published:2019-05-21 Issue:19 Volume:25 Page:2365-2372
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:WJG

Author:

Kuorda Hidekatsu,Abe Tamami,Fujiwara Yudai,Okamoto Takuya,Yonezawa Miki,Sato Hiroki,Endo Kei,Oikawa Takayoshi,Sawara Kei,Takikawa Yasuhiro

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference16 articles.

1. Hepatocellular carcinoma

2. Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update

3. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

4. Sorafenib in Advanced Hepatocellular Carcinoma

5. Antitumor Activity of Lenvatinib (E7080): An Angiogenesis Inhibitor That Targets Multiple Receptor Tyrosine Kinases in Preclinical Human Thyroid Cancer Models

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of artificial intelligence radiomics in the diagnosis, treatment, and prognosis of hepatocellular carcinoma;Computers in Biology and Medicine;2024-05

2. Noninvasive Visualization of Tumor Blood Vessels within Hepatocellular Carcinoma by Application of Superb Microvascular Imaging to Contrast-Enhanced Ultrasonography;Diagnostics;2024-03-23

3. Quantitative Parameters of Contrast-Enhanced Ultrasound Predicting the Response to Combined Immune Checkpoint Inhibitor and Anti-angiogenesis Therapies for Unresectable Hepatocellular Carcinoma;Ultrasound in Medicine & Biology;2024-03

4. A case of hepatocellular carcinoma with pseudoaneurysm formation upon lenvatinib administration;Clinical Journal of Gastroenterology;2024-01-28

5. Dynamic Contrast-Enhanced Ultrasound in the Prediction of Advanced Hepatocellular Carcinoma Response to Systemic and Locoregional Therapies;Cancers;2024-01-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3